Lakshmi Chauhan, MD
Infectious Disease
Locations
Practice Locations
UCHealth Infectious Disease Clinic - Anschutz Medical Campus
720-848-0191
Provider Expertise
Clinical Interest for Patients
My clinical interests include management of infections in immunocompromised patients including transplant and cancer patients, HIV and neurological infections.
Care Philosophy
I strive to provide patient-centered comprehensive infectious disease care by integrating the latest evidence and adopting a multidisciplinary approach. I value every patient interaction and try to understand their concerns, experiences and opinions. I believe in a holistic approach by taking into consideration the physical, mental and social issues.
Specialties
- Infectious Disease ( 2017 )
- Internal Medicine ( 2012 )
Conditions & Treatments
-
Infections
Bacterial, Fungal, Influenza, Pneumonia, Sexually Transmitted Diseases, Viral
Education & Training
Internships
University of Missouri-Columbia Program (2010)
Residency Program
University of Tennessee/Methodist Healthcare-Memphis Hospitals Program (2012)
Fellowships
University of Colorado (University Hospital) Program (2017)
Professional Memberships
IDSA, Member
Research & Grants
Grants
CEPS QI Grant (2018)
ACTIV-3 (2021)
Research Interests for Patients
I have various research interests. My current research is focused on 1) Clinical trials on therapeutic agents for emerging infections 2) Understanding the role of immunocompromised states in clinical presentation of various infections 2) Exploring potential biomarkers for diagnosing various types of infections based on host immune response 3) Frailty, neurocognitive changes following acute infections.
information for referring providers
Referral Contact Phone
720-848-0191
Clinical Interests for Referring Providers
My clinical interests include management of infections in immunocompromised patients including transplant and cancer patients, HIV and neurological infections.
Research Interest for Referring Providers
My current research is focused on 1) Clinical trials on therapeutic agents for emerging infections 2) Understanding the role of immunocompromised states in clinical presentation of various infections 2) Exploring potential biomarkers for diagnosing various types of infections based on host immune response 3) Frailty, neurocognitive changes following acute infections.
